🔎 Under the Radar: Kodiak Stock Surges as Eye Drug Matches Regeneron’s - WSJ

As reported by The Wall Street Journal

Shares of Kodiak Sciences surged more than 170% Monday—on pace for its largest one-day increase on record—after the company announced its eye drug matched Regeneron's blockbuster Eylea in a Phase 3 trial.Palo Alto, Calif.-based Kodiak said that more than half…

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on The Wall Street Journal ↗

Market Samachar is a news aggregator. This article was originally published by The Wall Street Journal. Tap the button above to read the full story on their site.

COMPANIES Sensex falls over 20% in dollar terms in 2026 as weak sentiment, rupee drag returns Stocks-Markets-Economic Times
COMPANIES KPIT Tech plunges 24% in 3 months as auto demand weakens Stocks-Markets-Economic Times
INDIAN Global Market Today: Asian shares rise as tech stocks lead, bonds in focus Markets-Economic Times
INDIAN Korean Stocks Face Early End to $40 Billion Buyback Support mint - markets
INDIAN Mideast Crude Oil Flows Hit 98% of Pre-War Level, JPMorgan Says mint - markets
INDIAN Raja Venkatraman recommends two stocks for 30 September mint - markets
INDIAN Lesson from 2026 IPOs: earnings execution beats listing gains mint - markets
INDIAN Jefferies's top stock recommendation: Buy rating with 27% upside | Indian share up 57% against IPO price in one month mint - markets

🔎 Under the Radar: Kodiak Stock Surges as Eye Drug Matches Regeneron’s - WSJ

More from Market Samachar